Patent Assignment
Reel/Frame 044780/0261
Assignment of Assignor's Interest
Recorded: 2017-11-09
Pages: 161
Assignor
CLARITY ACQUISITION II LLC
Executed: 2017-11-03
Assignee
CELULARITY, INC.
33 TECHNOLOGY DRIVE, WARREN, NEW JERSEY, 07059
Covered Properties
(316)
Method of Collecting Placental Stem Cells
Tissue Matrices Comprising Placeental Stem Cells, and Methods of Making the Same
Post-partum mammalian placenta, its use and placental stem cells therefrom
Application:
10/076,180 →
Publication:
US US20030032179A1
Embryonic-Like Stem Cells Derived from Post-Partum Mammalian Placenta, and Uses and Methods of Treatment Using Said Cells
Collagen biofabric and methods of preparation and use therefor
Application:
10/397,867 →
Publication:
US US20040048796A1
Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
Application:
10/511,354 →
Publication:
US US20050148034A1
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
Application:
10/511,355 →
Publication:
US US20050118715A1
Post-Partum Mammalian Placenta, Its Use and Placental Stem Cells Therefrom
Cytotherapeutics, cytotherapeutic units and methods for treatments using them
Application:
10/721,144 →
Publication:
US US20040171147A1
Use of umbilical cord blood to treat individuals having a disease, disorder or condition
Application:
10/779,369 →
Publication:
US US20040219136A1
Placental Stem Cells
Isolated Placental Perfusate and Placental Cells Isolated Therefrom
Treatment of Leg Ulcers Using Placenta Derived Collagen Biofabric
Immunomodulation Using Placental Stem Cells
Production of Oligodendrocytes from Placenta-Derived Stem Cells
Cytotherapeutics, Cytotherapeutic Units and Methods for Treatments Using Them
Use of umbilical cord blood to treat individuals having a disease, disorder or condition
Application:
11/593,348 →
Publication:
US US20070053888A1
Co-Culture of Placental Stem Cells and Stem Cells from a Second Source
Placental stem cell populations
Application:
11/648,804 →
Publication:
US US20080032401A1
Composition for Collecting Placental Stem Cells and Methods of Using the Composition
Placental Stem Cell Populations
Co-Culture of Placental Stem Cells and Stem Cells from a Second Source
Placental niche and use thereof to culture stem cells
Application:
11/811,447 →
Publication:
US US20080044848A1
Methods and Compositions for Treatment of Bone Defects with Placental Cell Populations
Tumor Suppression Using Placental Stem Cells
Human placental collagen compositions, and methods of making and using the same
Application:
11/973,902 →
Publication:
US US20080181935A1
Tissue Matrices Comprising Placental Stem Cells, and Methods of Making the Same
Placental Stem Cells Derived from Post-Partum Mammalian Placenta, and Uses and Methods of Treatment Using Said Cells
Co-culture of placental stem cells and stem cells from a second source
Application:
11/982,211 →
Publication:
US US20080175824A1
Placental stem cell populations
Application:
11/982,291 →
Publication:
US US20080152629A1
Treatment of Inflammatory Diseases Using Placental Stem Cells
CD34+,CD45- Placental Stem Cell-Enriched Cell Populations
Method of Producing Erythrocytes
Patent:
9,200,253 →
Application:
12/187,337 →
Angiogenic Cells from Human Placental Perfusate
Application:
12/239,679 →
Publication:
US US20090104164A1
Tumor Suppression Using Human Placental Perfusate and Human Placenta-Derived Intermediate Natural Killer Cells
Placental Stem Cells
Treatment of Premature Birth Complications
Application:
12/267,499 →
Publication:
US US20090136471A1
Treatment of Stroke Using Placental Stem Cells
Cell Composition and Methods of Making the Same
Treatment of Stroke Using Isolated Placental Cells
Methods and Compositions for Treatment of Bone Defects with Placental Cell Populations
Method of Propagating Cells
Amnion Derived Adherent Cells
Treatment of Diseases, Disorders or Conditions of the Lung Using Placental Cells
Application:
12/624,359 →
Publication:
US US20100143312A1
Treatment of Multiple Sclerosis Using Placental Stem Cells
Method of collecting placental cells
Application:
12/793,620 →
Publication:
US US20100323446A1
Tissue Matrices Comprising Placental Stem Cells
Method of Producing Erythrocytes Without Feeder Cells
Composition for Collecting and Preserving Placental Stem Cells and Methods of Using the Composition
Placental Stem Cell Populations
Treatment of Bone-Related Cancers Using Placental Stem Cells
Tumor Suppression Using Human Placenta-Derived Intermediate Natural Killer Cells and Immunomodulatory Compounds
Application:
13/071,437 →
Publication:
US US20110280849A1
Angiogenesis Using Placental Stem Cells
Treatment of Sarcoidosis Using Placental Stem Cells
Treatment of Leg Ulcers Using Placenta Derived Collagen Biofabric
Application:
13/089,029 →
Publication:
US US20110318401A1
Treatment of Rheumatoid Arthritis Using Placental Stem Cells
Application:
13/107,727 →
Publication:
US US20110280845A1
Treatment of Psoriasis Using Placental Stem Cells
Treatment of Diseases or Disorders Using Placental Stem Cells
Treatment of Brain or Spinal Cord Injury Using Placental Stem Cells
Application:
13/108,891 →
Publication:
US US20110223141A1
Treatment of Radiation Injury Using Placental Stem Cells
Tumor Suppression Using Placental Stem Cells
Application:
13/164,378 →
Publication:
US US20110250185A1
Methods of Generating Natural Killer Cells
Human Placental Collagen Compositions and Methods of Making and Using the Same
Treatment of Organ Injuries and Burns Using Placental Stem Cells
Treatment of Neurodegenerative Disease Using Placental Stem Cells
Application:
13/252,142 →
Publication:
US US20120020936A1
Placental Stem Cells Derived from Post-Partum Mammalian Placenta, and Uses and Methods of Treatment Using Said Cells
Application:
13/275,246 →
Publication:
US US20120034195A1
Placental Stem Cell Populations
Application:
13/276,268 →
Publication:
US US20120122215A1
Production of Oligodendrocytes from Placenta-Derived Stem Cells
Application:
13/293,037 →
Publication:
US US20120121550A1
Treatment of Spinal Cord Injury and Traumatic Brain Injury Using Placental Stem Cells
Application:
13/327,245 →
Publication:
US US20120156230A1
Treatment of Immune-Related Diseases and Disorders Using Amnion Derived Adherent Cells
Application:
13/327,315 →
Publication:
US US20120164114A1
Methods for Cryopreserving and Encapsulating Cells
Application:
13/340,528 →
Publication:
US US20120171295A1
Compositions Comprising Placental Stem Cells and Platelet Rich Plasma, and Methods of Use Thereof
Application:
13/340,557 →
Publication:
US US20120171161A1
Enhancement of Placental Stem Cell Potency Using Modulatory Rna Molecules
Human Placental Collagen Compositions, and Methods of Making and Using the Same
Placental Stem Cell Populations
Immunomodulation Using Placental Stem Cells
Placental Stem Cell Populations
Treatment of Pain Using Placental Stem Cells
Tumor Suppression Using Human Placental Perfusate and Human Placenta-Derived Intermediate Natural Killer Cells
Human Placental Collagen Compositions, and Methods of Making and Using the Same
Treatment of Premature Birth Complications
Application:
13/650,803 →
Publication:
US US20130259845A1
Treatment of Leg Ulcers Using Placenta Derived Collagen Biofabric
Application:
13/711,331 →
Publication:
US US20130184821A1
Amnion Derived Adherent Cells
Human Placental Collagen Compositions, and Methods of Making and Using the Same
Human Placental Collagen Compositions, and Methods of Making and Using the Same
Application:
13/777,426 →
Publication:
US US20130172531A1
Renovation and Repopulation of Decellularized Tissues and Cadaveric Organs by Stem Cells
Treatment of Inflammatory Diseases Using Placental Stem Cells
Human Placental Collagen Compositions, and Methods of Making and Using the Same
Treatment of Sarcoidosis Using Placental Stem Cells
Application:
14/027,787 →
Publication:
US US20140219970A1
Methods and Compositions for Treatment of Bone Defects with Placental Cell Populations
Method of Producing Erythrocytes Without Feeder Cells
Use Of Umbilical Cord Blood To Treat Individuals Having A Disease, Disorder Or Condition
Application:
14/085,366 →
Publication:
US US20140322175A1
Placental Stem Cell Populations
Methods and Compositons for Treatment of Bone Defects with Placental Cell Populations
Application:
14/218,465 →
Publication:
US US20140322177A1
Method of Collecting Placental Stem Cells
Placental Stem Cell Populations
Application:
14/298,637 →
Publication:
US US20150037316A1
Treatment of Amyotrophic Lateral Sclerosis Using Placental Stem Cells
Organoids Comprising Decellularized and Repopulated Placental Vascular Scaffold
Application:
14/367,631 →
Publication:
US US20150017140A1
Identification of Antitumor Compounds Using Placenta
Devices and Methods for Thawing Biological Material
Application:
14/380,018 →
Publication:
US US20150027434A1
Natural Killer Cells and Uses Thereof
Application:
14/421,059 →
Publication:
US US20150225697A1
Methods of Tissue Generation
Application:
14/425,505 →
Publication:
US US20150224226A1
Methods of Tissue Generation
Application:
14/425,523 →
Publication:
US US20150246072A1
Treatment of Pain Using Amnion Derived Adherent Cells
Application:
14/436,746 →
Publication:
US US20160166618A1
Treatment of Stroke Using Isolated Placental Cells
Application:
14/449,795 →
Publication:
US US20140341867A1
Immunomodulation Using Placental Stem Cells
Renovation and Repopulation of Decellularized Tissues and Cadaveric Organs by Stem Cells
Application:
14/531,110 →
Publication:
US US20150267170A1
Methods of Generating Natural Killer Cells
Treatment of Inflammatory Diseases Using Placental Stem Cells
Application:
14/550,524 →
Publication:
US US20150190433A1
Placental Stem Cells Derived From Post-Partum Mammalian Placenta, And Uses And Methods Of Treatment Using Said Cells
Application:
14/553,607 →
Publication:
US US20150174174A1
Enhancement of Placental Stem Cell Potency Using Modulatory Rna Molecules
Application:
14/598,357 →
Publication:
US US20150190434A1
Post-Partum Mammalian Placenta, Its Use and Placental Stem Cells Therefrom
Application:
14/616,167 →
Publication:
US US20150175959A1
Treatment of Leg Ulcers Using Placenta Derived Collagen Biofabric
Application:
14/631,496 →
Publication:
US US20150165085A1
Treating Oral Lesions Using Placental Extracellular Matrix
Application:
14/649,990 →
Publication:
US US20150313948A1
Anoikis Resistant Placental Stem Cells and Uses Thereof
Application:
14/651,891 →
Publication:
US US20150307879A1
Treatment of Pain Using Placental Stem Cells
Application:
14/692,307 →
Publication:
US US20150224148A1
Treatment of Leg Ulcers Using Placenta Derived Collagen Biofabric
Application:
14/696,836 →
Publication:
US US20150224219A1
Placental Stem Cell Populations
Placental Stem Cells Derived From Post-Partum Mammalian Placenta, And Uses And Methods Of Treatment Using Said Cells
Application:
14/742,345 →
Publication:
US US20150283184A1
Natural Killer Cells from Placenta
Enhanced Placental Stem Cells and Uses Thereof
Use of Placental Stem Cells in Treatment of Acute Kidney Injury
Application:
14/774,262 →
Publication:
US US20160030488A1
Improved Method of Making Extracellular Matrix Compositions
Application:
14/775,875 →
Publication:
US US20160030635A1
Treatment of Bone-Related Cancers Using Placental Stem Cells
Application:
14/792,067 →
Publication:
US US20150306150A1
Extracellular Matrix Composition Beads for Cell Culture
Application:
14/900,924 →
Publication:
US US20160304832A1
Amnion Derived Adherent Cells
Application:
14/919,884 →
Publication:
US US20160361366A1
Method of Producing Erythrocytes
Application:
14/925,346 →
Publication:
US US20170240860A1
Tumor Suppression Using Human Placental Perfusate and Human Placenta-Derived Intermediate Natural Killer Cells
Application:
14/942,337 →
Publication:
US US20160287635A1
Treatment of Pain Using Placental Stem Cells
Application:
14/951,655 →
Publication:
US US20160074439A1
Angiogenesis Using Placental Stem Cells
Application:
14/978,723 →
Publication:
US US20160106784A1
Method of Producing Erythrocytes Without Feeder Cells
Methods and Compositions for Treatment of Bone Defects with Placental Cell Populations
Application:
15/013,590 →
Publication:
US US20160151425A1
Therapy with Cells from Human Placenta and Hematopoietic Cells
Compositions Comprising Human Placental Perfusate Cells, Subpopulations Thereof, and Their Uses
Application:
15/036,649 →
Publication:
US US20160279171A1
Methods and Compositions for Treatment of Bone Defects with Placental Cell Populations
Micro-Organoids, and Methods of Making and Using the Same
Application:
15/117,669 →
Publication:
US US20160354408A1
Renovation and Repopulation of Decellularized Tissues and Cadaveric Organs by Stem Cells
Application:
15/141,123 →
Publication:
US US20170080032A1
Method of Collecting Placental Stem Cells
Organoids Comprising Decellularized and Repopulated Placental Vascular Scaffold
Application:
15/182,804 →
Publication:
US US20170128625A1
Co-Culture of Placental Cells and Stem Cells from a Second Source
Application:
15/189,914 →
Publication:
US US20160298084A1
Methods of Generating Natural Killer Cells
Application:
15/262,515 →
Publication:
US US20170002322A1
Placental Stem Cells Derived from Post-Partum Mammalian Placenta, and Uses and Methods of Treatment Using Said Cells
Application:
15/267,695 →
Publication:
US US20170224739A1
Treatment of Inflammatory Diseases Using Placental Stem Cells
Application:
15/271,429 →
Publication:
US US20170007648A1
Enhancement of Placental Stem Cell Potency Using Modulatory Rna Molecules
Application:
15/272,763 →
Publication:
US US20170000828A1
Treatment of Conditions and Complications in Infants
Application:
15/305,325 →
Publication:
US US20170042944A1
Cytotherapeutics, cytotherapeutic units and methods for treatments using them
Application:
15/362,300 →
Publication:
US US20170290862A1
Methods for Quantifying Particulates in Cell Culture
Treatment of Diabetic Foot Ulcer Using Placental Stem Cells
Application:
15/509,710 →
Publication:
US US20170290861A1
Placenta-Derived Adherent Cell Exosomes and Uses Thereof
Application:
15/517,438 →
Publication:
US US20170252379A1
Renovation and repopulation of decellularized cadaveric organs by stem cells
Application:
60/268,560 →
Methods for identification of modulators of angiogenesis using nonembryonic human cells
Application:
60/372,127 →
Methods of using PDE IV inhibitors to induce cell differentiation
Application:
60/384,251 →
Post-partum mammalian placenta, its use and placental stem cells therefrom
Application:
60/437,292 →
Treatment of leg ulcers using placenta derived collagen biofabric
Application:
60/699,441 →
Immunosuppression using placenta-derived stem cells
Application:
60/727,004 →
Oligodendrocytes from placenta-derived stem cells
Application:
60/727,601 →
Placenta-derived stem cell population
Application:
60/754,968 →
Composition for collecting and preserving placental stem cells and methods of using the composition
Application:
60/754,969 →
Placental niche and use thereof to culture stem cells
Application:
60/812,366 →
Tumor suppression using placental stem cells
Application:
60/835,627 →
Immunomodulation using placental stem cells
Application:
60/835,628 →
Placental stem cell populations
Application:
60/846,641 →
Human placental collagen compositions, and methods of making and using the same
Application:
60/850,131 →
Methods and compositions for treatment of bone defects with placental stem cell populations
Application:
60/853,971 →
Methods and compositions for treatment of bone defects with placental stem cell populations
Application:
60/855,629 →
Placental stem cell populations
Application:
60/901,066 →
Treatment of inflammatory diseases using placental stem cells
Application:
60/901,067 →
Placental stem cell populations enriched in CD34+CD45- cells and methods of use thereof
Application:
60/901,076 →
Placental stem cell populations
Application:
60/905,664 →
Production of hepatocytes from placenta-derived stem cells
Application:
60/906,064 →
Method of producing erythrocytes
Application:
60/963,894 →
Production of hepatocytes from placenta-derived stem cells
Application:
60/966,577 →
Angiogenic cells from human placental perfusate
Application:
60/995,679 →
Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
Application:
60/995,763 →
Methods and compositions for treatment of bone defects with placental stem cell populations
Application:
60/997,022 →
Treatment of premature birth complications
Application:
61/002,375 →
Tumor Suppression Using Human Placental Perfusate and Human Placenta-Derived Intermediate Natural Killer Cells
Application:
61/090,555 →
Treatment of Stroke Using Placental Stem Cells
Application:
61/090,565 →
Cell Composition and Methods of Making the Same
Application:
61/090,577 →
Osteogenic Placental Adherent Cells from Chorion and Uses Thereof
Application:
61/090,897 →
Treatment of Multiple Myeloma Using Osteogenic Placental Adherent Cells from Chorion
Application:
61/090,898 →
Amnion Derived Adherent Cells
Application:
61/116,248 →
Treatment of Diseases, Disorders or Conditions of the Lung Using Placental Cells
Application:
61/117,004 →
Tumor Suppression Using Human Placenta-Derived Intermediate Natural Killer Cells and Immunomodulatory Compounds
Application:
61/163,449 →
Method of Producing Erythrocytes Without Feeder Cells
Application:
61/222,930 →
Treatment of Bone-Related Cancers Using Placental Stem Cells
Application:
61/298,517 →
Treatment of Bone-Related Cancers Using Placental Stem Cells
Application:
61/307,821 →
Angiogenesis Using Placental Stem Cells
Application:
61/321,822 →
Treatment of Sarcoidosis Using Placental Stem Cells
Application:
61/322,272 →
Treatment of Bone-Related Cancers Using Placental Stem Cells
Application:
61/352,768 →
Methods of Generating Natural Killer Cells
Application:
61/363,981 →
Tumor Suppression Using Human Placenta-Derived Intermediate Natural Killer Cells and Immunomodulatory Compounds
Application:
61/397,692 →
Treatment of Spinal Cord Injury and Traumatic Brain Injury Using Placental Stem Cells
Application:
61/424,559 →
Treatment of Immune-Related Diseases and Disorders Using Amnion Derived Adherent Cells
Application:
61/424,593 →
Methods for Cryopreserving and Encapsulating Cells
Application:
61/428,427 →
Enhancement of Placental Stem Cell Potency Using Interfering RNAs
Application:
61/429,070 →
Treatment of Pain Using Placental Stem Cells
Application:
61/492,314 →
Methods of Generating Natural Killer Cells
Application:
61/497,897 →
Treatment of Pain Using Placental Stem Cells
Application:
61/548,663 →
Organoids Comprising Decellularized and Repopulated Placental Vascular Scaffold
Application:
61/579,942 →
Organoids Comprising Decellularized and Repopulated Placental Vascular Scaffold
Application:
61/592,350 →
Treatment of Pain Using Placental Stem Cells
Application:
61/594,985 →
Devices and Methods for Thawing Biological Material
Application:
61/601,406 →
Identification of Antitumor Compounds Using Placenta
Application:
61/602,524 →
Natural Killer Cells and Uses Thereof
Application:
61/682,706 →
Methods of Tissue Generation
Application:
61/696,479 →
Methods of Tissue Generation
Application:
61/696,487 →
Organoids Comprising Decellularized and Repopulated Placental Vascular Scaffold
Application:
61/696,527 →
Treatment of Pain Using Amnion Derived Adherent Cells
Application:
61/716,091 →
Treatment of Oral Lesions Using Placental Extracellular Matrix Compositions
Application:
61/734,665 →
Anoikis Resistant Placental Stem Cells and Uses Thereof
Application:
61/737,498 →
Natural Killer Cells from Placenta
Application:
61/761,176 →
Natural Killer Cells from Placenta
Application:
61/780,115 →
Treatment of Pain Using Amnion Derived Adherent Cells
Application:
61/783,752 →
Enhanced Placental Stem Cells and Uses Thereof
Application:
61/785,222 →
Use of Placental Stem Cells in Treatment of Acute Kidney Injury
Application:
61/785,252 →
Natural Killer Cells and Uses Thereof
Application:
61/799,211 →
Method of Making Extracellular Matrix Compositions
Application:
61/800,532 →
Extracellular Matrix Composition Beads for Cell Culture
Application:
61/838,693 →
Therapy with Cells from Human Placenta and Hematopoietic Cells
Application:
61/886,648 →
Therapy With Cells From Human Placenta And Hematopoietic Cells
Application:
61/890,057 →
Compositions Comprising Human Placental Perfusate Cells and Their Uses
Application:
61/905,076 →
Compositions Comprising Human Placental Perfusate Cells, Subpopulations Thereof, and Their Uses
Application:
61/905,077 →
Micro-Organoids, and Methods of Making and Using the Same
Application:
61/938,536 →
Treatment of Conditions and Complications in Infants
Application:
61/982,144 →
Extracellular Matrix Compositions
Application:
62/041,468 →
Methods for Quantifying Particulates in Cell Culture
Application:
62/049,895 →
Treatment of Diabetic Foot Ulcer Using Placental Cells
Application:
62/056,008 →
Placenta-Derived Adherent Cell Exosomes and Uses Thereof
Application:
62/062,046 →
Natural Killer Cells and Uses Thereof
Application:
62/098,560 →
Methods for Isolation of Platelets
Application:
62/098,795 →
Methods of Banking Placental Tissue and Cells
Application:
62/134,943 →
Treatment of Diabetic Foot Ulcer Using Placental Stem Cells
Application:
62/145,551 →
Treatment of Diabetic Foot Ulcer Using Placental Stem Cells
Application:
62/151,726 →
Angiogenesis Using Stimulated Placental Stem Cells
Application:
62/166,504 →
Treatment of Diabetic Foot Ulcer Using Placental Cells
Application:
62/170,757 →
Treatment of Diabetic Peripheral Neuropathy Using Placental Cells
Application:
62/218,885 →
Treatment of Diabetic Foot Ulcer Using Placental Stem Cells
Application:
62/220,620 →
Cell Potency Assay
Application:
62/234,404 →
Natural Killer Cells and ILC3 Cells and Uses Thereof
Application:
62/242,246 →
Natural Killer Cells and ILC3 Cells and Uses Thereof
Application:
62/272,984 →
Methods of Treating Acute Myeloid Leukemia Using Natural Killer Cells
Application:
62/333,186 →
Methods of Treating Acute Myeloid Leukemia Using Natural Killer Cells
Application:
62/333,187 →
Natural Killer Cells and ILC3 Cells and Uses Thereof
Application:
62/403,571 →
Methods of Treating Acute Myeloid Leukemia and Multiple Myeloma Using Natural Killer Cells
Application:
62/415,918 →
Methods of Treating Acute Myeloid Leukemia and Multiple Myeloma Using Natural Killer Cells
Application:
62/415,954 →
Treatment of Lymphedema and Related Conditions Using Placental Adherent Cells
Application:
62/430,123 →
Genetically Modified Natural Killer Cells
Application:
62/440,909 →
Methods of Treating Acute Myeloid Leukemia and Multiple Myeloma Using Natural Killer Cells
PCT:
PCT/US2017/031255 ↗
Natural Killer Cells and ILC3 Cells and Uses Thereof
PCT:
PCT/US2016/056988 ↗
Cell Potency Assay
PCT:
PCT/US2016/054058 ↗
Treatment of Diabetic Peripheral Neuropathy Using Placental Cells
PCT:
PCT/US2016/051571 ↗
Angiogenesis Using Stimulated Placental Stem Cells
PCT:
PCT/US2016/034003 ↗
Methods of Banking Placental Tissue and Cells
PCT:
PCT/US2016/022865 ↗
Natural Killer Cells and Uses Thereof
PCT:
PCT/US2015/068055 ↗
Methods for Isolation of Platelets
PCT:
PCT/US2015/068044 ↗
Placenta-Derived Adherent Cell Exosomes and Uses Thereof
PCT:
PCT/US2015/054629 ↗
Treatment of Diabetic Foot Ulcer Using Placental Stem Cells
PCT:
PCT/US2015/052276 ↗
Methods for Quantifying Particulates in Cell Culture
PCT:
PCT/US2015/049621 ↗
Extracellular Matrix Compositions
PCT:
PCT/US2015/046690 ↗
Treatment of Conditions and Complications in Infants
PCT:
PCT/US2015/026610 ↗
Micro-Organoids, and Methods of Making and Using the Same
PCT:
PCT/US2015/015157 ↗
Compositions Comprising Human Placental Perfusate Cells, Subpopulations Thereof, and Their Uses
PCT:
PCT/US2014/065665 ↗
Therapy with Cells from Human Placenta and Hematopoietic Cells
PCT:
PCT/US2014/058774 ↗
Extracellular Matrix Composition Beads for Cell Culture
PCT:
PCT/US2014/043611 ↗
Improved Method of Making Extracellular Matrix Compositions
PCT:
PCT/US2014/027102 ↗
Use of Placental Stem Cells in Treatment of Acute Kidney Injury
PCT:
PCT/US2014/025266 ↗
Enhanced Placental Stem Cells and Uses Thereof
PCT:
PCT/US2014/025202 ↗
Natural Killer Cells from Placenta
PCT:
PCT/US2014/014632 ↗
Anoikis Resistant Placental Stem Cells and Uses Thereof
PCT:
PCT/US2013/074892 ↗
Treatment of Oral Lesions Using Placental Extracellular Matrix Compositions
PCT:
PCT/US2013/073593 ↗
Treatment of Pain Using Amnion Derived Adherent Cells
PCT:
PCT/US2013/065653 ↗
Methods of Tissue Generation
PCT:
PCT/US2013/057806 ↗
Methods of Tissue Generation
PCT:
PCT/US2013/057803 ↗
Natural Killer Cells and Uses Thereof
PCT:
PCT/US2013/054677 ↗
Identification of Antitumor Compounds Using Placenta
PCT:
PCT/US2013/027288 ↗
Devices and Methods for Thawing Biological Material
PCT:
PCT/US2013/026819 ↗
Organoids Comprising Decellularized and Repopulated Placental Vascular Scaffold
PCT:
PCT/US2012/071192 ↗
Treatment of Amyotrophic Lateral Sclerosis Using Placental Stem Cells
PCT:
PCT/US2012/054493 ↗
Treatment of Pain Using Placental Stem Cells
PCT:
PCT/US2012/040081 ↗
Enhancement of Placental Stem Cell Potency Using Modulatory Rna Molecules
PCT:
PCT/US2011/067867 ↗
Compositions Comprising Placental Stem Cells and Platelet Rich Plasma, and Methods of Use Thereof
PCT:
PCT/US2011/067785 ↗
Methods for Cryopreserving and Encapsulating Cells
PCT:
PCT/US2011/067716 ↗
Treatment of Spinal Cord Injury and Traumatic Brain Injury Using Placental Stem Cells
PCT:
PCT/US2011/065170 ↗
Treatment of Immune-Related Diseases and Disorders Using Amnion Derived Adherent Cells
PCT:
PCT/US2011/065158 ↗
Improved Methods of Generating Natural Killer Cells
PCT:
PCT/US2011/043831 ↗
Angiogenesis Using Placental Stem Cells
PCT:
PCT/US2011/031335 ↗
Treatment of Sarcoidosis Using Placental Stem Cells
PCT:
PCT/US2011/031330 ↗
Treatment of Bone-Related Cancers Using Placental Stem Cells
PCT:
PCT/US2011/022333 ↗
Method of Producing Erythrocytes Without Feeder Cells
PCT:
PCT/US2010/040707 ↗
Improved Method of Collecting Placental Cells
PCT:
PCT/US2010/037161 ↗
Tumor Suppression Using Human Placenta-Derived Intermediate Natural Killer Cells and Immunomodulatory Compounds
PCT:
PCT/US2010/028885 ↗
Treatment of Diseases, Disorders or Conditions of the Lung Using Placental Cells
PCT:
PCT/US2009/065509 ↗
Amnion Derived Adherent Cells
PCT:
PCT/US2009/065152 ↗
Methods and Compositions for Treatment of Bone Defects with Placental Cell Populations
PCT:
PCT/US2009/004801 ↗
Treatment of Stroke Using Isolated Placental Cells
PCT:
PCT/US2009/004741 ↗
Improved Cell Composition and Methods of Making the Same
PCT:
PCT/US2009/004740 ↗
Treatment of Premature Birth Complications
PCT:
PCT/US2008/012540 ↗
Tumor Suppression Using Human Placental Perfusate and Human Placenta-Derived Intermediate Natural Killer Cells
PCT:
PCT/US2008/011251 ↗
Angiogenic Cells from Human Placental Perfusate
PCT:
PCT/US2008/011167 ↗
Treatment of Inflammatory Diseases Using Placental Stem Cells
PCT:
PCT/US2008/001831 ↗
Hepatocytes and Chondrocytes from Adherent Placental Stem Cells; and CD34+, CD45- Placental Stem Cell-Enriched Cell Populations
PCT:
PCT/US2008/001830 ↗
Methods and Compositions for Treatment of Bone Defects with Placental Cell Populations
PCT:
PCT/US2007/022545 ↗
Human Placental Collagen Compositions, and Methods of Making and Using the Same
PCT:
PCT/US2007/021677 ↗
Tumor Suppression Using Placental Stem Cells
PCT:
PCT/US2007/017622 ↗
Placental Niche and Use Thereof to Culture Stem Cells
PCT:
PCT/US2007/013507 ↗
Improved Composition for Collecting and Preserving Placetal Stem Cells and Methods of Using the Composition
PCT:
PCT/US2006/049493 ↗
Placental Stem Cell Populations
PCT:
PCT/US2006/049491 ↗
Immunomodulation Using Placental Stem Cells
PCT:
PCT/US2006/040148 ↗
Production of Oligodendrocytes from Placenta-Derived Stem Cells
PCT:
PCT/US2006/040145 ↗
Treatment of Leg Ulcers Using Placenta Derived Collagen Biofabric
PCT:
PCT/US2006/027364 ↗
Use of Umbilical Cord Blood to Treat Individuals Having a Disease, Disorder or Condition
PCT:
PCT/US2004/004388 ↗
Cytotherapeutics, Cytotherapeutic Units and Methods for Treatments Using Them
PCT:
PCT/US2003/038143 ↗
Methods for Identification of Modulators of Angiogenesis, Compounds Discovered, Thereby, and Methods of Treatment Using the Compounds
PCT:
PCT/US2003/011578 ↗
Modulation of Stem and Progenitor Cell Differentiation, Assays, and Uses Thereof
PCT:
PCT/US2003/011190 ↗
Collagen Biofabric and Methods of Preparation and Use Therefor
PCT:
PCT/US2003/009304 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 6, 2002
From: HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 012977/0741 →
Assignment of Assignor's Interest
Dec 11, 2002
From: HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 013571/0872 →
Assignment of Assignor's Interest
Feb 7, 2003
From: HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 013743/0637 →
Assignment of Assignor's Interest
Aug 11, 2003
From: HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 014377/0829 →
Assignment of Assignor's Interest
Sep 25, 2003
From: HARIRI, ROBERT J.; KAPLUNOVSKY, ALEKSANDR M.; MURPHY, PATRICIA A.
To: CELLULAR THERAPEUTICS DIVISION OF CELGENE
Reel/Frame 014526/0477 →
Assignment of Assignor's Interest
May 19, 2004
From: HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 015340/0205 →
Assignment of Assignor's Interest
Jun 28, 2004
From: HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 015514/0697 →
Assignment of Assignor's Interest
Jul 21, 2004
From: HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 015591/0445 →
Assignment of Assignor's Interest
Apr 1, 2005
From: MOUTOUH-DE PARSEVAL, LAURE A.; CHAN, KYLE W.H.
To: SIGNAL PHARMACEUTICALS, LLC
Reel/Frame 016419/0358 →
Assignment of Assignor's Interest
Apr 1, 2005
From: HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 016419/0447 →
Assignment of Assignor's Interest
Apr 1, 2005
From: STIRLING, DAVID I
To: CELGENE CORPORATION
Reel/Frame 016419/0350 →
Assignment of Assignor's Interest
Apr 19, 2006
From: HARIRI, ROBERT J.
To: AMTHROGENESIS CORPORATION
Reel/Frame 017496/0694 →
Assignment of Assignor's Interest
Apr 19, 2006
From: PAYVANDI, FARIBOURZ; WU, LEI; STIRLING, DAVID I.; YE, QIAN
To: CELGENE CORPORATION
Reel/Frame 017496/0262 →
Assignment of Assignor's Interest
Feb 12, 2007
From: HEIDARAN, MOHAMMAD
To: ANTHROGENESIS CORPORATION
Reel/Frame 018881/0221 →
Assignment of Assignor's Interest
Feb 12, 2007
From: HARIRI, ROBERT; SMIELL, JANICE
To: ANTHROGENESIS CORPORATION
Reel/Frame 018880/0262 →
Assignment of Assignor's Interest
Apr 26, 2007
From: EDINGER, JAMES W; HEIDARAN, MOHAMMAD
To: ANTHROGENESIS CORPORATION
Reel/Frame 019217/0171 →
Assignment of Assignor's Interest
Apr 27, 2007
From: PALUDAN, CASPER; EDINGER, JAMES; HARBACHEUSKI, RYHOR; MURRAY, ROSEANN
To: ANTHROGENESIS CORPORATION
Reel/Frame 019223/0652 →
Assignment of Assignor's Interest
Jun 20, 2008
From: EDINGER, JAMES; YE, QIAN; WANG, JIA-LUN; HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 021128/0337 →
Assignment of Assignor's Interest
Jun 27, 2008
From: HEIDARAN, MOHAMMAD; WANG, JIA-LUN; YE, QIAN; ZEITLIN, ANDREW
To: ANTHROGENESIS CORPORATION
Reel/Frame 021166/0096 →
Assignment of Assignor's Interest
Jul 2, 2010
From: HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 024634/0025 →
Assignment of Assignor's Interest
Jul 2, 2010
From: HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 024633/0976 →
Assignment of Assignor's Interest
Jul 2, 2010
From: HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 024631/0611 →
Assignment of Assignor's Interest
Nov 8, 2010
From: HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 025322/0746 →
Assignment of Assignor's Interest
Nov 8, 2010
From: HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 025322/0784 →
Assignment of Assignor's Interest
Aug 11, 2016
From: ANTHROGENESIS CORPORATION, A NEW JERSEY CORPORATION, D/B/A CELGENE CELLULAR THERAPEUTICS
To: HLI CELLULAR THERAPEUTICS, LLC, A DELAWARE LIMITED LIABILITY COMPANY
Reel/Frame 039411/0443 →